Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-13-025785)

Filing Details

Accession Number:: 0001209191-13-025785
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-05-13 15:37:03
Reporting Period:: 2013-05-10

Filing Date:: 2013-05-13
Accepted Time:: 2013-05-13 15:37:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
59478	Lilly Eli & Co	LLY	Pharmaceutical Preparations (2834)	350470950

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1479079	N Jeffrey Simmons	Lilly Corporate Center Indianapolis IN 46285	Svp&Pres.,Elanco Animal Health	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-05-10	10,000	$54.49	51,750	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	941	Indirect	401(k)

Footnotes

This transaction was executed in multiple trades at prices ranging from $54.49 to $54.51. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.